BeOne Medicines AG banner

BeOne Medicines AG
SSE:688235

Watchlist Manager
BeOne Medicines AG Logo
BeOne Medicines AG
SSE:688235
Watchlist
Price: 248.45 CNY -0.84% Market Closed
Market Cap: ¥221.7B

Wall St Price Targets

Price Forecast
Based on 8 analysts

+49% Upside
from ¥248.45 today

BeOne Medicines AG (688235)’s 12-month stock price forecast through October 2027 has a consensus target of ¥369.84, implying 49% upside. The forecast is based on price targets from 8 Wall Street analysts.

Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for BeOne Medicines AG yet.

BeOne Medicines AG Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is BeOne Medicines AG's stock price target?
Price Target
369.84 CNY

According to Wall Street analysts, the average 1-year price target for BeOne Medicines AG is 369.84 CNY with a low forecast of 308.66 CNY and a high forecast of 476.81 CNY.

What is the Revenue forecast for BeOne Medicines AG?
Projected CAGR
11%

Over the last 6 years, the compound annual growth rate for Revenue has been 53%. The projected CAGR for the next 8 years is 11%.

What is the Gross Profit forecast for BeOne Medicines AG?
Projected CAGR
61%

Over the last 6 years, the compound annual growth rate for Gross Profit has been 54%. The projected CAGR for the next -3 years is 61%.

What is the Operating Income forecast for BeOne Medicines AG?
Projected CAGR
33%

The compound annual growth rate for Operating Income over the next 8 years is 33%.

What is the Pre-Tax Income forecast for BeOne Medicines AG?
Projected CAGR
73%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 73%.

What is the Net Income forecast for BeOne Medicines AG?
Projected CAGR
45%

The compound annual growth rate for Net Income over the next 8 years is 45%.

Back to Top